Conavi Medical Corp.
CNVIF
$0.4571
$0.094225.96%
| 09/30/2024 | 06/30/2024 | 09/30/2023 | |||
|---|---|---|---|---|---|
| Revenue | 352.70K | 293.10K | 1.46M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 352.70K | 293.10K | 1.46M | ||
| Cost of Revenue | 326.30K | 335.40K | 436.10K | ||
| Gross Profit | 26.40K | -42.40K | 1.03M | ||
| SG&A Expenses | 1.32M | 1.66M | 1.27M | ||
| Depreciation & Amortization | 176.00K | 162.20K | 234.10K | ||
| Other Operating Expenses | 209.70K | -- | 169.20K | ||
| Total Operating Expenses | 5.05M | 6.79M | 5.75M | ||
| Operating Income | -4.70M | -6.50M | -4.29M | ||
| Income Before Tax | -11.79M | -9.52M | -5.26M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -11.79M | -9.52M | -5.26M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -11.79M | -9.52M | -5.26M | ||
| EBIT | -4.70M | -6.50M | -4.29M | ||
| EBITDA | -4.59M | -6.38M | -4.19M | ||
| EPS Basic | -1.91 | -1.55 | -0.85 | ||
| Normalized Basic EPS | -0.72 | -0.77 | -0.55 | ||
| EPS Diluted | -1.91 | -1.55 | -0.85 | ||
| Normalized Diluted EPS | -0.72 | -0.77 | -0.55 | ||
| Average Basic Shares Outstanding | 6.17M | 6.16M | 6.16M | ||
| Average Diluted Shares Outstanding | 6.17M | 6.16M | 6.16M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
